| Filed On | Filing |
|---|---|
| 24 May 2024 |
Form 3: Inhibrx, Inc., 10% owner · Inhibrx Biosciences Inc
Holds 100 shares of Common Stock, par value $0.0001 per share |
| 29 Oct 2021 |
Form 3: Vuori Kristiina Md, Director
No securities owned |
| 25 Aug 2020 |
Form 3: Viking Global Investors Lp, 10% owner and 7 others
Holds 1,115,623 shares of Common Stock |
| 18 Aug 2020 | Form 3: Ra Capital MANAGEMENT, L.p., 10% owner and 2 others |
| 18 Aug 2020 |
Form 3: Lappe Mark, Director and 1 other
Holds 3,090,252 shares of Common Stock |
| 18 Aug 2020 | Form 3: Deck Kelly, Chief Financial Officer |
| 18 Aug 2020 |
Form 3: Deveraux Quinn L., 10% owner
Holds 2,749,953 shares of Common Stock |
| 18 Aug 2020 |
Form 3: Wagner Klaus W., Chief Medical Officer
Holds 391,183 shares of Common Stock |
| 18 Aug 2020 |
Form 3: Manhard Kimberly, Director
No securities owned |
| 18 Aug 2020 |
Form 3: Forsyth Douglas, Director
Holds 515,835 shares of Common Stock |
| 18 Aug 2020 |
Form 3: Kayyem Jon Faiz, Director and 1 other
Holds 3,396,101 shares of Common Stock |
| 18 Aug 2020 |
Form 3: Eckelman Brendan P., Director and 1 other
Holds 2,749,953 shares of Common Stock |
Loading...
